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During the past 30 years in became evident that neuro-
transmitter are important regulators of the immune sys-
tem. The presence of nerve fibers and the release of
neurotransmitters within lymphoid organs represents a
mechanism by which signals from the central nervous sys-
tem influence the immune cell functions. Neurotransmit-
ter per se cannot induce any new function in immune cells
but they are mainly responsible for the "fine-tuning" of an
immune response. There is already a broad knowledge on
the influence of neurotransmitter on B cells or CD4 lym-
phocytes/T helper cells, but with regard to CD8 positive
cytotoxic T lymphocytes (CTLs) there are still many open
questions. Therefore, we conducted the present study in
order to complement the picture of neurotransmitter
action on this leukocyte subset. We investigated the influ-
ence of norepinephrine, dopamine and substance P on
the key functions of CTLs in vitro: activation, extravasa-
tion, migration and cytotoxicity. The activation of CTLs
via CD3/CD28 cross-linking was inhibited by all of the
three investigated neurotransmitters via mechanisms that
involve PKA as investigated by the use of specific cAMP
analoga. Furthermore, these cells showed a decrease in
ERK1/2 phosphorylation and their level of IL-2 mRNA
was reduced. Addition of high dose IL-2 was able to
reverse the inhibiting effect of the neurotransmitters. With
regard to extravasation we found dopamine to be a strong
inducer of the adhesion of naïve CD8 lymphocytes to
endothelium. In contrast, norepinephrine induced the
adhesion of activated/effector T cells. Norepinephrine
increases the IL-8 release from endothelium thereby lead-
ing to an increased adhesion of CXCR1 positive cells. We
found CXCR1 to be mainly expressed on activated, per-
forin positive CTLs. All of the investigated neurotransmit-
ter increased the spontaneous migratory activity of naïve
CTLs with dopamine being the strongest inducer. But acti-
vated CTLs showed a reduced migratory activity in the
presence of norepinephrine and substance P which seems
to be mediated via the Epac/Rap1 pathway as investigated
by the use of specific cAMP analoga. Dopamine had no
effect on activated CTLs since dopamine receptors are
down-regulated during the activation process. The ability
of activated CTLs to release their cytotoxic granula in
response to CD3 cross-linking was analyzed by measuring
the beta-hexosamidase release. This process was not influ-
enced by any of the neurotransmitters used. In conclu-
sion, there is no general scheme for neurotransmitters to
act either stimulatory or inhibitory on leukocytes. In con-
trast, the effect of a neurotransmitter depends on the leu-
kocyte subtype and its activation state or phenotype. Thus,
neurotransmitters are specific modulators of certain
immune functions.
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